Teratoma — Trials · CancerIndex

Clinical trials

Registered studies

45 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00432094	Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors	completed	Phase 2	23	Masonic Cancer Center, University of MinnesotaOTHER	1	May 17, 2022	clinicaltrials
NCT01037790	Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer	completed	Phase 2	304	Abramson Cancer Center at Penn MedicineOTHER	1	Mar 11, 2021	clinicaltrials
NCT02300987	A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression	completed	Phase 2	10	Novartis PharmaceuticalsINDUSTRY	4	Oct 26, 2020	clinicaltrials
NCT00470366

Data updated 22 days agoSource updated May 17, 2022source: clinicaltrials